相关实验视频

Updated: Sep 12, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

在食道状细胞癌中,第一线免疫疗法与化学放射疗法相结合的真实研究

Xiaohan Zhao¹, Chengang Weng², Wuhan Yang³

¹Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University Cancer Institute, No. 12 Jiankan Road, Chang'an District, Shijiazhuang, 050011, China.

Scientific reports

|August 4, 2025

概括

一线免疫疗法与化学放射疗法相结合,在食道状细胞癌 (ESCC) 中显示出显著的抗瘤活性. 辐射覆盖和淋巴细胞计数等关键因素影响整体存活率,这表明一种有前途的治疗方法.

科学领域:

在瘤学瘤学.
免疫治疗是一种免疫疗法.
胃肠道瘤学胃肠道瘤学

背景情况:

食道状细胞癌 (ESCC) 仍然是一个重大的全球健康挑战.
目前ESCC的治疗模式通常涉及多式联络方法.
优化一线治疗策略对于改善患者的治疗结果至关重要.

研究的目的:

评估ESCC患者的第一线免疫疗法与化疗放射治疗相结合的疗效,安全性和复发模式.
为了确定影响ESCC患者的生存期的预后因素,用这种联合方式治疗ESCC患者.

主要方法:

79名符合条件的ESCC患者的回顾性分析.
评估总生存率 (OS),无进展生存率 (PFS),客观反应率 (ORR) 和疾病控制率 (DOR).
分析与治疗相关的不良事件 (trAEs) 和治疗失败模式.

主要成果:

中位数PFS为14.6个月;中位数OS没有达到.
观察到高的ORR (82.3%) 和DOR (96.2%).
临床阶段,免疫治疗周期,辐射覆盖和淋巴细胞计数等因素显著影响了OS和PFS.

结论:

第一线免疫疗法加上化学放射疗法显示出强大的抗瘤活性和可接受的ESCC安全性.
对所有病变的辐射,连续治疗和更高的淋巴细胞计数与改善的预后相关.
通过大规模随机对照试验进行进一步验证是有必要的.

关键词:

化疗化疗是一种化学疗法.食管状细胞癌的癌症.免疫治疗是一种免疫疗法.预测预测预测预测辐射疗法辐射疗法与治疗相关的不良事件

更多相关视频

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

相关概念视频

Treatment Resistant Cancers

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...